Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) is an artificial-intelligence-driven cardiovascular diagnostics company that completed its de-SPAC merger with Mana Capital Acquisition Corp in October 2022, with Mana Capital LLC serving as the SPAC's sponsor. Mana Capital Acquisition Corp conducted its IPO in 2021 and targeted the healthcare technology sector. The combined company develops epigenetic-based molecular tests for early detection and risk stratification of cardiovascular disease. The 10-Q filed on November 7, 2022 represents CDIO's first quarterly report as a publicly traded post-merger entity, covering its near-term operating results and financial position following the business combination. Sign up for SpacDesk to access full filing histories, deal timelines, and analytics on CDIO and hundreds of other SPAC transactions.